Newsfeeds - Spark Newswire

1 minute read

Plains All American Q2 EPS $0.30 Beats $0.18 Estimate, Sales $16.36B Beat $13.28B Estimate

Today, 1:55 PM

Plains All American (NASDAQ:PAA) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.18 by 66.67 percent. This is a 30.43 percent increase over earnings of $0.23 per share from

PAA

1 minute read

Analyst Ratings

Analyst Ratings for Plains All American

By Benzinga Insights

Today, 1:55 PM

Over the past 3 months, 7 analysts have published their opinion on Plains All American (NASDAQ:PAA) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

PAA

1 minute read

Wolfe Research Downgrades Plains All American to Peer Perform

By Benzinga Newsdesk

Today, 1:55 PM

Wolfe Research analyst Keith Stanley downgrades Plains All American (NASDAQ:PAA) from Outperform to Peer Perform.

PAA

1 minute read

Barclays Maintains Equal-Weight on Plains All American, Lowers Price Target to $12

By Benzinga Newsdesk

Today, 1:55 PM

Barclays analyst Theresa Chen maintains Plains All American (NASDAQ:PAA) with a Equal-Weight and lowers the price target from $13 to $12.

PAA

2 minute read

Analyst Ratings

Where Plains All American Stands With Analysts

By Benzinga Insights

Today, 1:55 PM

Within the last quarter, Plains All American (NASDAQ:PAA) has observed the following analyst ratings:

PAA

1 minute read

UBS Maintains Buy on Plains All American, Raises Price Target to $17

By Benzinga Newsdesk

Today, 1:55 PM

UBS analyst Joseph Parkhill maintains Plains All American (NASDAQ:PAA) with a Buy and raises the price target from $16 to $17.

PAA

1 minute read

Legal
News

Plains All American Pipeline Says On April 27, Parties Entered A Stipulation And Agreement Of Settlement Compromise, And Release To Settle Lawsuit

By Michael Horton

Today, 1:55 PM

-Reuters

PAA

1 minute read

Credit Suisse Upgrades Plains All American to Outperform, Raises Price Target to $14

By Benzinga Newsdesk

Today, 1:55 PM

Credit Suisse analyst Spiro Dounis upgrades Plains All American (NASDAQ:PAA) from Neutral to Outperform and raises the price target from $13 to $14.

PAA

1 minute read

Mizuho Maintains Buy on Plains All American, Raises Price Target to $14

By Benzinga Newsdesk

Today, 1:55 PM

Mizuho analyst Gabriel Moreen maintains Plains All American (NASDAQ:PAA) with a Buy and raises the price target from $13 to $14.

PAA

27 minute read

Earnings Scheduled For May 4, 2022

By Benzinga Insights

Today, 1:55 PM

Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

ABC